Strong Support for the Brain Benefits of Aerobic Activity

A comprehensive literature review provides “compelling” support for recommending aerobic physical activity to help prevent or slow dementia and brain aging. Medscape Medical News

WHO Offers Low-Cost Ways to Reduce Noncommunicable Diseases

The World Health Organization (WHO) reports on methods to reduce disease burden for as little as $1.20 per person per year. Medscape Medical News

Alcohol Linked to Colorectal Cancer Risk

The more alcohol consumed per day, the greater the colorectal cancer risk, a new study suggests. Medscape Medical News

Patients OK With Surgical Trainees — But Only in Theory (CME/CE)

(MedPage Today) — In general, patients support having surgical trainees participate in their procedures, but that willingness declines when patients are confronted with more personalized scenarios, researchers found.

Insurance Type Matters in Heart Failure Care (CME/CE)

(MedPage Today) — Heart failure patients covered by Medicare or Medicaid or who have no insurance at all received fewer evidence-based therapies than those with private insurance, researchers found.

Obama Plan Cuts Billions from Medicare, Medicaid

WASHINGTON (MedPage Today) — President Obama on Monday defended his 10-year plan to cut $3 trillion from the federal deficit — a plan that includes $320 billion in proposed cuts to Medicare and Medicaid, largely by cutting payments for healthcare services.

Patient Transfer Tied to Outcome in STEMI System (CME/CE)

(MedPage Today) — Even in an established regional system of care for patients with ST-segment elevation MI (STEMI), treatment delays still occur when patients need to be transferred between centers, researchers found.

FDA Okays Denosumab for Cancer-Induced Bone Loss

WASHINGTON (MedPage Today) — The FDA has approved the osteoporosis drug denosumab (Prolia) as a treatment for bone loss in women with breast cancer and men with non-metastatic prostate cancer.

ICAAC: E. Coli Superbug May Bow to Azithromycin (CME/CE)

CHICAGO (MedPage Today) — Azithromycin (Zithromax) given to patients with a new, ultra-dangerous strain of E. coli appeared to help rid them of the pathogen, German researchers said here.

FDA Okays Denosumab for Cancer-Induced Bone Loss

WASHINGTON (MedPage Today) — The FDA has approved the osteoporosis drug denosumab (Prolia) as a treatment for bone loss in women with breast cancer and men with non-metastatic prostate cancer.